Citius Pharmaceuticals Inc (CTXR)
0.1345
-0.03
(-18.53%)
USD |
NASDAQ |
Nov 22, 16:00
0.1301
0.00 (0.00%)
After-Hours: 16:04
Citius Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Citius Oncology Inc | -- |
| Agilent Technologies Inc | 0.4967 |
| Merck & Co Inc | 0.8568 |
| Cara Therapeutics Inc | 0.00 |
| Moleculin Biotech Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 97.09M |
| Total Liabilities (Quarterly) | 10.81M |
| Shareholders Equity (Quarterly) | 85.68M |